Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Corcept Therapeutics
Corcept Therapeutics
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
AbbVie
The Methodist Hospital Research Institute
Psyence Australia Pty Ltd
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
AbbVie
Brigham and Women's Hospital
Aadi Bioscience, Inc.
Emory University
AbbVie
National Institutes of Health Clinical Center (CC)
Tel-Aviv Sourasky Medical Center
Shandong Cancer Hospital and Institute
Korea University Guro Hospital
Aalborg University Hospital
Baylor College of Medicine
Shandong Cancer Hospital and Institute
M.D. Anderson Cancer Center
Exelixis
Jules Bordet Institute
Catalysis SL
Loyola University
The University of Hong Kong
Sumitomo Pharma America, Inc.
Hoffmann-La Roche
Sheba Medical Center
University of Manchester
University of Kentucky
PharmaMar
Northwestern University
Vall d'Hebron Institute of Oncology
Nektar Therapeutics
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Cristal Therapeutics
Eli Lilly and Company
Jiangsu Cancer Institute & Hospital
Jiangsu Cancer Institute & Hospital
Quest PharmaTech Inc.
Lumos Pharma
Catharina Ziekenhuis Eindhoven
Eli Lilly and Company
Immunitor LLC
Masonic Cancer Center, University of Minnesota
Novartis
Belgian Gynaecological Oncology Group
University College, London
Incyte Corporation
Pfizer